About us Newsletter News Widget Media Inquiries

Media Inquiries

Your experience will be better in the app

Install

Sign Up | Log In

Menu

Contact Us Terms of Service Support Privacy Policy Archive

© 2024 Otherweb

Subscribe to our newsletter

Everything you need to know about today's news — in your inbox each morning.

It’s free

By continuing, you agree to Otherweb's Terms of Service and acknowledge you've read our Privacy Policy

Follow

Featured Podcast EpisodesThe Other Web

Alex Fink

Zuckerman vs Zuckerberg

July 14, 2024

Ethan Zuckerman is a professor at the University of Massachusetts Amherst and a scholar of digital media. He and his team work to understand the contemporary digital world and build social media systems that are focused on communities, not on profits. Ethan is currently suing Meta (i.e. Facebook) in a landmark case that might (and likely should) change our interpretation of section 230. Please tune in to hear the details of the case and the various ways it could change the social media landscape. It's fascinating!

Prof. Jeff Jarvis - Rewriting Media's Business Model (Yet Again)

May 24, 2024

Jeff Jarvis is a journalism professor at the City College in New York (CUNY), the author of six books, and the cohost of the successful podcast "This week in Google and AI". Jeff spent many years teaching entrepreneurial journalism - and God knows journalism could use some entrepreneurial spirit, right about now. Please check out Jeff's books, The Gutenberg Parenthesis and Magazine, both from Bloomsbury (discount codes here: gutenbergparenthesis.com).

Donald Robertson - Where Philosophy Meets Psychology

June 22, 2024

Our guest today is Donald Robertson - Donald is a cognitive-behavioral psychotherapist and author of several books, including How to Think Like a Roman Emperor and, more recently, Marcus Aurelius: The Stoic Emperor. He is one of the founders of the Modern Stoicism nonprofit organization and the founder and president of the Plato's Academy Centre in Athens, Greece. He was born in Scotland but now lives in Montreal, Canada. His upcoming book, How to Think Like Socrates, will be released later this year, and can be preordered on Amazon, Barnes and Noble, or anywhere else books are generally sold.

Rick Edmonds - Analyzing the Financial Decline of Legacy Media

July 8, 2024

Rick Edmonds is the media business analyst for the Poynter Institute, a school and study center for working journalists. He has been doing research and writing for 25 years on the financial decline of legacy media, newspapers particularly, and the rise of new media alternatives. His reporting and commentary appear regularly on the Poynter Online site. He has spoken to conference groups in the U.S.A. and in Paris, Norway, Madrid, Vienna and Chile.

Jonathan Green - How To Make ChatGPT and Other Tools Useful (Right Now)

July 5, 2024

Welcome to the Otherweb. Our guest today is Jonathan Green - a bestselling author of hundreds of books, a celebrity ghostwriter, and an expert in using artificial intelligence tools to their utmost capacity. This is the best conversation I've had on the practical implications of ChatGPT and how regular people can augment their own capabilities by using these tools as a shortcut.

1h 4m

News from drug discoveries

Stay current with all the latest and breaking news about drug discoveries, compare headlines and perspectives between news sources on stories happening today. In total, 607 stories have been published about drug discoveries which Ground News has aggregated in the past 3 months.

Recent news

ScienceDaily

ScienceDaily

Study identifies potential new drug for Parkinson's-related cognitive decline, dementia

View summary

ScienceDaily

ScienceDaily

Eradivir's EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies

View summary

Cryptopolitan

Cryptopolitan

Crypto whale points to new DeSci trend with biotech token gains

Cryptopolitan

View summary

Last of the week

CNBC

CNBC

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

Read full article

Ars Technica

Ars Technica

Novo Nordisk sells hit weight-loss drug in China—at fraction of US price

Read full article

CityNews

CityNews

Woman, 40, charged in toddler's death in Niagara Falls, Ont.

Read full article

CTV News Toronto

CTV News Toronto

Toddler dies from drug toxicity in Niagara Falls, Ont.

Read full article

ELLE

ELLE

Turns Out a New Pill for Dogs Could Help Them (And Us) Live Longer

Read full article

BBC

BBC

Popular weight-loss drug Wegovy goes on sale in China

Read full article

Latest news stories

ScienceDaily

ScienceDaily

Multiple sclerosis drug may help with poor working memory

View summary

ScienceBlog.com

ScienceBlog.com

Breakthrough Gut Pain Pill: A Safer, Opioid-Free Solution from Oxytocin

ScienceBlog.com

View summary

Australian Science Media Centre

Australian Science Media Centre

Promising daily tablet increases growth in children with dwarfism

Australian Science Media Centre

View summary

Yle News

Yle News

Finnish Customs catches drug mule who swallowed 100 cocaine capsules

Yle News

View summary

EurekAlert!

EurekAlert!

Diabetes drug shows promise in protecting kidneys

EurekAlert!

View summary

Australian Science Media Centre

Australian Science Media Centre

Increased risk of internal bleeding for people on blood thinners who take anti-inflammatories

Australian Science Media Centre

View summary

Good News Network

Good News Network

Caterpillar Fungus Used in Chinese Medicine Slows the Growth of Cancer Cells, Shows New Study

Good News Network

View summary

NBC News

NBC News

New weight loss drugs are coming, and they could burn more fat with fewer side effects

NBC News

View summary

MIT News

MIT News

Cancer biologists discover a new mechanism for an old drug

MIT News

View summary

Drexel Home

Drexel Home

Children Exposed to Antiseizure Meds During Pregnancy Face Neurodevelopmental Risks, Drexel Study Finds

Drexel Home

View summary

The Motley Fool

The Motley Fool

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More

View summary